YU86390A - Salts fo elastine with increased solubility - Google Patents

Salts fo elastine with increased solubility

Info

Publication number
YU86390A
YU86390A YU00863/90A YU86390A YU86390A YU 86390 A YU86390 A YU 86390A YU 00863/90 A YU00863/90 A YU 00863/90A YU 86390 A YU86390 A YU 86390A YU 86390 A YU86390 A YU 86390A
Authority
YU
Yugoslavia
Prior art keywords
salts
elastine
azelastine
increased solubility
acid
Prior art date
Application number
YU00863/90A
Other languages
English (en)
Inventor
H Hettche
R Muckenschnabel
G Scheffler
I Fleischhauer
W Morick
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of YU86390A publication Critical patent/YU86390A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
YU00863/90A 1989-05-05 1990-05-04 Salts fo elastine with increased solubility YU86390A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914859 1989-05-05

Publications (1)

Publication Number Publication Date
YU86390A true YU86390A (en) 1992-05-28

Family

ID=6380164

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00863/90A YU86390A (en) 1989-05-05 1990-05-04 Salts fo elastine with increased solubility

Country Status (17)

Country Link
US (4) US5086050A (xx)
EP (1) EP0396069B1 (xx)
JP (1) JPH02295987A (xx)
AT (1) ATE107643T1 (xx)
AU (1) AU622022B2 (xx)
CA (1) CA2016089C (xx)
DD (1) DD294254A5 (xx)
DE (2) DE59006184D1 (xx)
DK (1) DK0396069T3 (xx)
ES (1) ES2055216T3 (xx)
FI (1) FI902244A0 (xx)
HU (1) HU206110B (xx)
IE (1) IE63662B1 (xx)
NO (1) NO901985L (xx)
NZ (1) NZ233546A (xx)
PT (1) PT93946B (xx)
YU (1) YU86390A (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP4138910B2 (ja) 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
WO1999021565A1 (en) * 1997-10-24 1999-05-06 Cornell Research Foundation, Inc. Nutritional supplement for cerebral metabolic insufficiencies
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7694694B2 (en) * 2004-05-10 2010-04-13 The Aerospace Corporation Phase-change valve apparatuses
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2522365T (pt) 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (xx) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
ATE60598T1 (de) * 1985-11-11 1991-02-15 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
DE3850044D1 (de) * 1987-11-13 1994-07-14 Asta Medica Ag Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤

Also Published As

Publication number Publication date
JPH02295987A (ja) 1990-12-06
DD294254A5 (de) 1991-09-26
FI902244A0 (fi) 1990-05-04
HUT53901A (en) 1990-12-28
ATE107643T1 (de) 1994-07-15
DE4013696A1 (de) 1990-11-08
CA2016089A1 (en) 1990-11-05
HU902678D0 (en) 1990-09-28
US5859003A (en) 1999-01-12
US5086050A (en) 1992-02-04
EP0396069A1 (de) 1990-11-07
US5998403A (en) 1999-12-07
NO901985L (no) 1990-11-06
AU5473690A (en) 1990-11-08
DK0396069T3 (da) 1994-07-25
AU622022B2 (en) 1992-03-26
NO901985D0 (no) 1990-05-04
DE59006184D1 (de) 1994-07-28
ES2055216T3 (es) 1994-08-16
US6017909A (en) 2000-01-25
EP0396069B1 (de) 1994-06-22
PT93946B (pt) 1996-11-29
IE63662B1 (en) 1995-05-31
CA2016089C (en) 1998-12-01
IE901639L (en) 1990-11-05
PT93946A (pt) 1991-01-08
NZ233546A (en) 1991-09-25
HU206110B (en) 1992-08-28

Similar Documents

Publication Publication Date Title
YU86390A (en) Salts fo elastine with increased solubility
DE3167687D1 (en) Nutrient solution for complete extra-buccal feeding and for an enhanced production of energy, and manufacturing process
GR3004119T3 (xx)
EP0159040A3 (en) Pyridine derivatives and production thereof
KR100214903B1 (en) Process for producing aminomethanephosphonic acid and aminomethylphosphinic acids
ES2152097T3 (es) Empleo de esteres de acidos hidroxicarboxilicos como espesantes.
ES8605769A1 (es) Un procedimiento para la preparacion de un peptido
KR960002228B1 (en) Water soluble monoazo naphtolcarbonic acid compound, the
NZ514573A (en) Beta-hydroxyalkylamides, process for their production and their use
TW221806B (xx)
EP0521613A3 (en) Concentrated water soluble organic lanthanide salts
DE59806469D1 (de) Verfahren zur herstellung von 3-hydroxy-2-methylbenzoesäure
MX9804222A (es) Procedimiento para la obtencion de acidos estilben- disulfonicos o sus derivados, que contienen bis-alcoxi- triazinil-amino.
PT101847A (pt) Peptido substituido derivado de lisina e prolina
IL140156A0 (en) Process for preparing 1-alkylpyrazole-5- carboxilic esters
IN161962B (xx)
JPS542235A (en) Corrosion inhibitor
RO96550A2 (ro) Procedeu de preparare a unor esteri ai acidului alfa-naftilacetic
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
DE19881189D2 (de) Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
ES2058968T3 (es) Procedimiento para eliminar o reducir la cantidad de 1-carboxi-1-fosfonociclopentano-3-ona del acido tecnico 2-fosfonobutano-1,2,4-tricarboxilico mediante lejias decolorantes.
ATE250620T1 (de) Verfahren zur herstellung von etoposid
ES2058030A1 (es) Procedimiento de preparar acido 1-( (2s)-metil-3-mercaptopropionil-pirrolidina-(2s)-carboxilico.
RO96974B1 (ro) Procedeu pentru stabilizarea produsului dinosebacetat